Zobrazeno 1 - 10 of 12 pro vyhledávání: '"Inge Schwersenz"'
1
Akademický článek
SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy
Autor: Astrid Pechmann, Kirsten König, Günther Bernert, Kristina Schachtrup, Ulrike Schara, David Schorling, Inge Schwersenz, Sabine Stein, Adrian Tassoni, Sibylle Vogt, Maggie C. Walter, Hanns Lochmüller, Janbernd Kirschner
Publikováno v: Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-6 (2019)
Abstract Background Survival and quality of life for patients affected by spinal muscular atrophy (SMA) are thought to have improved over the last decade due to changes in care. In addition, targeted treatments for SMA have been developed based on a
Externí odkaz: https://doaj.org/article/a83b67a28e984288b50f76b05e169552
Zobrazit plný text záznamu
3
Treatment evaluation in patients with 5q-associated spinal muscular atrophy : Real-world experience
Autor: Thomas Meyer, Wolfgang Löscher, Christoph Kleinschnitz, Maggie C. Walter, Berthold Schrank, René Günther, Andreas Hermann, Bianca Dräger, Janbernd Kirschner, Tim Hagenacker, Inge Schwersenz, Claudia D. Wurster, Albert C. Ludolph
Publikováno v: Der Nervenarzt. 90:343-351
Die spinale Muskelatrophie (SMA) ist eine progressive, autosomal-rezessive neurodegenerative Erkrankung mit einer Inzidenz von 1:10.000 Lebendgeburten. Mit besserem Verstandnis der molekularen Basis der SMA in den letzten beiden Jahrzehnten richtete
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba458de2201108ba77801081c0137531
https://doi.org/10.1007/s00115-018-0653-7
Zobrazit plný text záznamu
7
[Treatment evaluation in patients with 5q-associated spinal muscular atrophy : Real-world experience]
Autor: Maggie C, Walter, Bianca, Dräger, Rene, Günther, Andreas, Hermann, Tim, Hagenacker, Christoph, Kleinschnitz, Wolfgang, Löscher, Thomas, Meyer, Berthold, Schrank, Inge, Schwersenz, Claudia D, Wurster, Albert C, Ludolph, Janbernd, Kirschner
Publikováno v: Der Nervenarzt. 90(4)
Spinal muscular atrophy (SMA) is a progressive autosomal recessive neurodegenerative disease with an incidence of 1:10,000 live births. With a deeper understanding of the molecular basis of SMA in the past two decades, a major focus of therapeutic de
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8f376f105b72e68c4d3b66bc816fed98
https://pubmed.ncbi.nlm.nih.gov/30617569
Zobrazit plný text záznamu
8
SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy
Autor: Astrid, Pechmann, Kirsten, König, Günther, Bernert, Kristina, Schachtrup, Ulrike, Schara, David, Schorling, Inge, Schwersenz, Sabine, Stein, Adrian, Tassoni, Sibylle, Vogt, Maggie C, Walter, Hanns, Lochmüller, Janbernd, Kirschner
Publikováno v: Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-6 (2019)
Orphanet Journal of Rare Diseases
Background Survival and quality of life for patients affected by spinal muscular atrophy (SMA) are thought to have improved over the last decade due to changes in care. In addition, targeted treatments for SMA have been developed based on a better un
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3c396d53d7eae737a2f42ae0c7dccc47
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85060249960
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje